Discovering the future of infection prevention and control – 6th Edition Infection Control, Sterilization & Decontamination Virtual Conference 2021

Discovering the future of infection prevention and control – 6th Edition Infection Control, Sterilization & Decontamination Virtual Conference 2021

July 12th, 2021- Following up the legacy of 5 very successful annuals in UK & Europe geographies, we are proud to to announce the 6th Edition Infection Control, Sterilization & Decontamination Virtual Conference, Middle East, scheduled for 5th-6th October, 2021. This edition will focus on key topics like the utilization of reprocessed equipment to disinfect or sterilize medical devices, decontamination of surgical instruments, endoscopic devices, respiratory care devices, and reusable hemodialysis machines. How Patient-to-patient pathogen transmission via medical devices can be entirely prevented by properly sterilising medical devices. These topics…

Read More

Delve into the new era of genome sequencing- MarketsandMarkets Advanced Genetic Sequencing Virtual Conference

Delve into the new era of genome sequencing- MarketsandMarkets Advanced Genetic Sequencing Virtual Conference

July 12th, 2021- Genome sequencing is providing physicians with more data about the causes of cancer and changing the way some forms of the disease are treated. Continued advancements in sequencing technologies have fuelled the development of new sequencing applications. MarketsandMarkets is proud to announce the first edition of Advanced Genetic Sequencing Virtual Conference scheduled to be held on 23rd & 24th of September 2021. A 2-day content-rich program combining stellar expertise from world-renowned keynote and featured speakers in the areas of Genetics & Genomics an expanding field of biology…

Read More

Discussing Top Disruptions in Big Data & Analytics at MarketsandMarkets Big Data Analytics CRYSTAL BALL EVENT

Discussing Top Disruptions in Big Data & Analytics at MarketsandMarkets Big Data Analytics CRYSTAL BALL EVENT

MarketsandMarkets Big Data Analytics CRYSTAL BALL EVENT to be held on 16th September 2021 where 4 Great Minds discuss about Top disruptions in Big Data & Analytics Ecosystem in a 90-minute session. Big data can enable companies to increase operational efficiencies and reduce costs. Big data solutions and services store and analyse structured and unstructured data from IT operations and turn it into relevant information and insights. Numerous companies are implementing big data solutions and services to evaluate their internal processes and enhance operations. Big data implementation assists companies to…

Read More

Embracing next-generation technologies for new-age digitization- MarketsandMarkets Plant Digitization Virtual Conference 2021

Embracing next-generation technologies for new-age digitization- MarketsandMarkets Plant Digitization Virtual Conference 2021

July 08th, 2021- Digitization – through SMART TECHNOLOGIES and CONNECTED DEVICES- is increasing PRODUCTIVITY, EFFICENCY AND ACCURACY in manufacturing and process-based enterprises. Industry experts believe, in future virtually all plant operations will be converted into a digital format.  We, along with HIMA as our co-sponsor, are proud to present you the APAC edition of MarketsandMarkets Plant Digitization Virtual Conference which is scheduled to take place on 19th – 20th August 2021. The 2-day conference will extend the opportunity to explore the technological advances and innovations in the field of Plant…

Read More

Unleash the Power of IoT-based Predictive Maintenance at the 3rd Annual MarketsandMarkets INDUSTRY 4.0: CYBERSECURITY & IIOT

Unleash the Power of IoT-based Predictive Maintenance at the 3rd Annual MarketsandMarkets INDUSTRY 4.0: CYBERSECURITY & IIOT

July, 08th 2021 – 3rd Annual MarketsandMarkets INDUSTRY 4.0: CYBERSECURITY & IIOT virtual conference to be held on the 23rd-24th Septemberwill hostindustry giants like LEGO Group, Ford Motors, Bearing Point, EY, Whirlpool EMEA & more to deliver the key industry attributes in form user-based case studies. The conference aims to explore the top technology trends paving the way for a PdM Revolution along with adoption of IoT & cybersecurity architecture in Industry 4.0 use cases for manufacturers, factory managers and asset managers & stakeholders involved in tech adoption. The 2-day…

Read More

Explore New Business Strategies at 2nd Annual MarketsandMarkets Competitive and Market Intelligence Summit – US

Explore New Business Strategies at 2nd Annual MarketsandMarkets Competitive and Market Intelligence Summit – US

2nd Annual MarketsandMarkets Competitive and Market Intelligence Summit – US to be held on 21st – 22nd September 2021 will host industry giants like Lenovo, VMware, Cognizant, IBM, JPMorgan Chase, BMC Software, HPE and many more. The global Business Intelligence market size to grow from USD 23.1 billion in 2020 to USD 33.3 billion by 2025, CAGR of 7.6% during the forecast period. Various factors such as the growing focus on digital transformation, rising investments in analytics, rising demand for dashboards for data visualization, increase in adoption of cloud, and…

Read More

Identifying How is Big Data Impacting BFSI at 2nd Annual Big Data Virtual Masterclass Conference

Identifying How is Big Data Impacting BFSI at 2nd Annual Big Data Virtual Masterclass Conference

2nd Annual Big Data Virtual Masterclass Conference to be held on 22nd – 23rd July 2021 will host industry giants like Snap Finance, IBM, TD, GE Capital, American Express, State Farm, USAA, National Bank of Canada, CIBC and many more to present on Big Data Tools & Solutions, case studies and innovations in BFSI sector. With an increasing amount of data, it has become vital for organizations to incorporate Big Data Analytics into their business processes. The event focuses on Addressing the data quality issues, Big Data architectures to be…

Read More

“Tumor-targeted costimulatory trimerbodies for cancer immunotherapy.”- A brief discussion with Juan Perez Villar, CEO, LeadArtis.

“Tumor-targeted costimulatory trimerbodies for cancer immunotherapy.”-  A brief discussion with Juan Perez Villar, CEO, LeadArtis.

Doctor in Immunology from the Autonomous University of Madrid (Spain), extensive international career in the biopharmaceutical industry at Astellas Inc. and Bristol-Myers Squibb Co. (USA). Experienced R&D leader in immune-oncology (IO). Previously, participated in preclinical development of CD28 biologic modulators for inflammatory conditions, small molecule tyrosine kinase inhibitors and fully human antibodies for advanced solid tumors at Leadartis. He advanced the company from start to capitalize on the immuno-oncology (IO) market. Evaluated and repositioned the platform technology to create IO bispecific antibody dominance and created a proprietary next generation product…

Read More

Héctor Pérez Montoyo, of Ability Pharma discusses his research on, “ABTL0812, a new immunotherapeutic anticancer agent at phase 2b clinical stage.”

Héctor Pérez Montoyo, of Ability Pharma discusses his research on, “ABTL0812, a new immunotherapeutic anticancer agent at phase 2b clinical stage.”

Héctor’s work has always focused on understanding the molecular pathophysiological mechanisms leading to autoimmunity and cancer development, investigating mechanism of action of newly developed molecules to treat such diseases. He started his career in 2006 when he moved to UT Southwestern Medical Center in Dallas (EEUU), to carry out this thesis in developing novel therapeutic antibodies in murine models of human autoimmune diseases. After obtaining his Ph.D., he combined two postdoctoral grants in Barcelona (Metastasis and Transformation group in Bellvitge Biomedical Research Center) and in Valencia (Autoimmune Pathology Lab in…

Read More

Dr. William Williams of Briacell Therapeutics Corporation talks about Personalized, off-the-shelf cellular immunotherapy for cancer

Dr. William Williams of  Briacell Therapeutics Corporation talks about Personalized, off-the-shelf cellular immunotherapy for cancer

Dr. Williams is the President and CEO of BriaCell Corporation, where he has shepherded Bria-IMT™ into the clinic, established positive proof-of-concept, forged a collaboration with Incyte for novel combinations and coordinated the development of an off-the-shelf personalized approach to cancer immunotherapy. While at Incyte Corporation as Head of Exploratory Development, he brought numerous molecules into the clinic and established proof of concept in several disease areas. At GlaxoSmithKline he worked to bring several molecules into the clinic, ran a biomarker laboratory and spearheaded initiatives to utilize emerging technologies in drug…

Read More